Peptide Initiative

Peptide profile · Immune

Thymopoietin

Thymic hormone that supports T-cell development and immune function, with the active fragment thymopentin (TP-5) used in clinical research

Limited human trialsResearch compound
Minutes to hours in plasmaHalf-life
Moderate with subcutaneous injectionBioavailability
5454Molecular weight

Molecular formula

C246H404N66O73

CAS number
67632-30-6
PubChem
16132313
Developed · 1975
Gideon Goldstein, Memorial Sloan-Kettering Cancer Center / Immunobiology Research Institute

Amino acid sequence

49-amino acid polypeptide with active pentapeptide fragment (thymopentin/TP-5: Arg-Lys-Asp-Val-Tyr)

Immune Cell DevelopmentThymopoietin directly induces differentiation of T-cell precursors into mature helper and cytotoxic T-cells, with robust evidence from multiple clinical studies.

9.2

Post-Surgical RecoveryRestores T-cell function and prevents immune suppression after major surgery, with randomized trials showing restoration of normal immune parameters.

8.5

Cancer Immunotherapy EnhancementCombines effectively with chemotherapy to improve anti-tumor immunity while reducing hematologic toxicity, with established use in cancer treatment protocols.

8.0

Ratings out of 10.

50mg

Every documented dose level

PhaseDoseFrequency
6 weeks to several months50 mg (as the active thymopentin/TP-5 pentapeptide)Three times weekly
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for supporting immune function during cancer treatment & recovering immune function after surgery

Best for

  • Cancer Treatment Support

    Used alongside chemotherapy to maintain immune function and reduce treatment side effects while enhancing anti-tumor immunity

  • Post-Surgical Immune Recovery

    Helps restore T-cell function and prevent immune depression following major surgery or serious medical stress

  • HIV-Related Immune Support

    Combined with antiretroviral therapy to support T-cell populations and improve immune response

Consider alternatives if

General immune supportThymosin alpha 1 (Tα1)ThymulinZinc supplementationProbiotics
Cancer immunotherapyCAR-T cell therapyCheckpoint inhibitors (nivolumab, pembrolizumab)Interferon alpha
Post-surgical recoveryThymosin alpha 1IL-2 therapyGranulocyte-macrophage colony-stimulating factor (GM-CSF)

Do not use if

  • You have myasthenia gravis or neuromuscular junction disorders
  • You are pregnant or breastfeeding
  • You have severe allergies to thymic peptides or bovine-derived proteins
  • You have active, uncontrolled autoimmune disease

Use with caution if

  • You have history of autoimmune conditions
  • You are taking high-dose immunosuppressive medications
  • You have bleeding disorders or are on anticoagulants
  • You have compromised injection sites or severe infections

Not sure?

Compare Thymopoietin with similar peptides to find the best fit for your goals.

Route

Subcutaneous injection (primary method); can be intravenous under medical supervision

Best sites

  • Upper outer arm (abdomen side, away from bone)
  • Abdomen (2 inches away from belly button on all sides)
  • Outer thigh (mid-thigh area)
  • Rotate sites to prevent local reactions

The Thymopoietin injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.

3 common side effects · 4 serious

Emergency signs first, then what this page and MedlinePlus say.

Thymopoietin is a naturally-derived thymic hormone with a well-characterized mechanism but limited human safety data.

Most clinical experience comes from thymopentin (TP-5), the active pentapeptide fragment. It is generally well-tolerated but has important safety considerations, particularly regarding neuromuscular effects.

Safety profile based on limited clinical trials primarily using thymopentin, a simplified fragment. Full thymopoietin research is more limited. Always use under appropriate medical guidance.


Common side effects · experienced by some users

Injection site redness or swelling

Mild to moderate redness, warmth, or swelling at injection site lasting a few hours to a day

Management
Apply ice pack for 10 minutes, avoid rubbing area, rotate injection sites, use topical antihistamine if itching

Mild fever

Low-grade fever (99-101°F) within 24 hours of injection, may indicate immune activation

Management
Rest, stay hydrated, monitor temperature, take acetaminophen if uncomfortable

Transient lymphocytosis

Temporary increase in white blood cells, normal immune response to treatment

Management
Monitor with blood tests, usually resolves within days, indicates therapeutic effect

Serious side effects

Neuromuscular weakness or myasthenia-like symptoms

Muscle weakness, difficulty swallowing, drooping eyelids, shortness of breath - potential neuromuscular blocking effects of thymopoietin

Management
STOP use immediately, seek emergency medical attention, inform doctor of thymopoietin use

Severe allergic reaction (anaphylaxis)

Difficulty breathing, throat tightness, rapid heartbeat, severe swelling

Management
STOP use immediately, call emergency services (911), use epinephrine auto-injector if available

Autoimmune flare

Worsening of autoimmune symptoms or new onset autoimmune manifestations

Management
Stop use, contact healthcare provider immediately, may need immunosuppressive therapy

Less commonMild to moderate fatigueTemporary headachesJoint or muscle aches

These typically resolve with continued use or dose adjustment.


Stop and seek help if

  • Severe neuromuscular weakness or myasthenia-like symptoms appear
  • Severe allergic reactions occur
  • Signs of autoimmune disease flare up
  • Persistent fever over 101.5°F
  • Severe injection site reactions with spreading redness or warmth
  • Pregnancy is discovered
  • Diagnosed with myasthenia gravis or neuromuscular disorder

This information is educational. Always consult with a healthcare provider before starting, stopping, or changing thymopoietin use. Emergency symptoms require immediate medical attention.


With other peptides

  • Thymosin alpha 1: May have synergistic immune effects, generally safe to combine
  • Thymulin: Complementary thymic hormones, can be used together
  • Growth hormone-releasing peptides: No major interactions reported

With medications

  • Chemotherapy agents: Enhanced immunotherapy effect, may reduce side effects
  • Antiretroviral drugs (HIV): Compatible, may improve immune recovery
  • Indomethacin: Synergistic effect in post-surgical immune recovery
  • Live vaccines: May reduce vaccine efficacy, space dosing
  • Immunosuppressive drugs (corticosteroids, calcineurin inhibitors): Potential conflict, avoid or use with caution
  • Anticoagulants: No direct interaction but monitor injection site carefully

With supplements

  • Zinc: Complementary immune support, can combine safely
  • Vitamin D: May enhance immune effects, generally compatible
  • Probiotics: Support gut immunity, no major interactions
  • Curcumin: Potential anti-inflammatory synergy
  • Omega-3 fatty acids: Support immune cell function, compatible

Limited human trials · first signs week 1

Evidence level

Limited human trials

60/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)


How it works

Thymopoietin is a hormone made by your thymus gland (a small gland in your chest that trains immune cells).

Think of it like a coach that teaches young immune cells called T-cells how to do their job properly. When you inject thymopoietin, you're giving your immune system extra coaching to make more T-cells and help them work better. This can help your body fight infections and cancer.

The most commonly used part is thymopentin, which is just the five most important amino acids (building blocks) from the whole thymopoietin molecule.

The deeper mechanism

Thymopoietin is a 49-amino acid polypeptide hormone secreted by thymic epithelial cells that plays a central role in T-cell lymphopoiesis and differentiation.

The peptide works primarily through its bioactive pentapeptide fragment, thymopentin (TP-5: Arg-Lys-Asp-Val-Tyr, residues 32-36), which exerts immunomodulatory effects through multiple mechanisms: (1) Promotes differentiation of T-cell precursors into mature helper and cytotoxic T-cells by inducing expression of differentiation markers including CD4, CD8, and TCR expression; (2) Enhances IL-2 production and T-cell proliferation through restoration of IL-2 receptor expression; (3) Reduces T-cell apoptosis through anti-apoptotic signaling; (4) Modulates Th1/Th2 balance toward Th1 responses important for cellular immunity.

Clinically, thymopoietin and thymopentin support immune recovery in immunocompromised states including post-surgical immunosuppression, HIV-related CD4 depletion, and chemotherapy-induced lymphopenia.

The peptide also exhibits neuromuscular effects through interaction with acetylcholine receptors, which can be both therapeutic and potentially problematic in neuromuscular disorders.


What to expect

  1. Week 1

    What you might notice

    • Mild injection site reactions (redness, warmth)
    • Possible low-grade fever within first 24 hours
    • Mild fatigue or flu-like feeling
    • No dramatic changes yet

    What's normal

    • Local injection reactions are expected
    • Mild fever indicates immune activation
    • Body is still adjusting to peptide

    What's next

    • Continue dosing schedule
    • Rotate injection sites to minimize local reactions
    • Monitor temperature and general feelings
  2. Week 2-3

    What you might notice

    • Reduced injection site reactions
    • Improved energy or reduced fatigue
    • Better recovery after physical activity
    • Blood work may show increased lymphocytes

    What's normal

    • Stabilization of immune response
    • Body adapting to treatment
    • Transient lymphocytosis is expected and positive

    What's next

    • Continue standard dosing if tolerating well
    • Schedule blood tests to assess T-cell counts
    • Monitor for any neuromuscular symptoms
  3. Week 4-6

    What you might notice

    • Improved immune function markers
    • Reduced infection frequency
    • Better response to other treatments (if used with chemotherapy)
    • Sustained improvement in T-cell populations

    What's normal

    • Cumulative immune improvement
    • More stable baseline energy levels
    • Results align with expected therapeutic timeline

    What's next

    • Assess response to therapy with healthcare provider
    • Determine if continuing, cycling, or stopping treatment
    • Plan follow-up blood work

Signs it's working

Blood Work Markers

  • Increased total lymphocyte count
  • Improved CD4+ T-cell count (if HIV-positive)
  • Improved helper T-cell ratio
  • Better lymphocyte proliferation in lab tests

Signs it's working

Clinical Outcomes

  • Reduced frequency or severity of infections
  • Faster recovery from illness
  • Improved tolerance to chemotherapy
  • Better overall energy and immune function
  • Reduced cancer progression during treatment

Signs it's working

Post-Surgical Recovery

  • Faster wound healing
  • Reduced post-surgical infections
  • Restored normal T-cell distribution
  • Return to normal immune-dependent functions

Not seeing results?

Common reasons

  • Not enough time has passed - immune changes take 2-4 weeks to manifest
  • Injection site rotation inadequate - causing excessive local inflammation
  • Dosing schedule inconsistency - missing doses or irregular timing reduces effect
  • Concurrent immunosuppressive therapy - high-dose corticosteroids or immunosuppressants block thymopoietin effect
  • Underlying condition preventing response - advanced cancer, severe malnutrition, or uncontrolled infections reduce effectiveness

What's the difference between thymopoietin and thymopentin?

Thymopoietin is the full 49-amino acid hormone from your thymus gland. Thymopentin (TP-5) is a smaller, 5-amino acid active fragment (residues 32-36) that contains the key therapeutic effects. Most clinical research and use has been with thymopentin because it's simpler, easier to make, and still provides the immune benefits. Both work similarly to boost T-cell production.

How quickly will I see immune improvement?

Most people don't notice dramatic changes right away. Immune system changes typically take 2-4 weeks to become measurable. You might see improved energy or faster recovery from illness within the first month. Blood tests showing improved T-cell counts are usually the first measurable changes, often visible within 2-3 weeks.

Can I use thymopoietin if I have an autoimmune disease?

No, thymopoietin should NOT be used if you have active autoimmune disease like lupus, rheumatoid arthritis, or Hashimoto's thyroiditis, because it strengthens the immune system which could make autoimmune symptoms worse. However, it may have been studied in rheumatoid arthritis at very specific doses and routes - always check with your doctor first.

What should I do if I develop muscle weakness after starting thymopoietin?

Stop using it immediately and contact your doctor. Muscle weakness, difficulty swallowing, or drooping eyelids could indicate neuromuscular blocking effects. This is a serious side effect. Do not ignore it - get medical help right away. This is why thymopoietin should never be used by people with myasthenia gravis.

Can I combine thymopoietin with chemotherapy?

Yes, in fact, combining thymopoietin or thymopentin with chemotherapy may improve outcomes. Research shows it can make chemotherapy more effective while reducing some side effects on blood cell production. However, this should only be done under medical supervision, and your oncologist should be aware you are using it.

How often should I rotate my injection sites?

Rotate your injection sites with every dose. You have three main areas: upper arm (abdomen side), abdomen, and outer thigh. Use a different site for each injection to prevent excessive local reactions. Even within the abdomen, vary the spot (upper left, upper right, lower left, lower right).

Is thymopoietin FDA-approved?

No, thymopoietin is not FDA-approved as a drug in the United States. Most clinical research has used thymopentin, the active fragment. Thymopoietin and thymopentin are available in some countries outside the U.S. and in research settings, but they are not available as prescription medications in the U.S.

Can I take thymopoietin if I'm pregnant or breastfeeding?

No, thymopoietin should not be used during pregnancy or while breastfeeding. There is not enough safety data in pregnant women, and it could potentially affect fetal immune development. If you are trying to conceive, discuss with your doctor when it would be safe to stop.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Thymopoietin, on one page.

Thymopoietin dosing protocol

Medical disclaimer

Thymopoietin is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026

50 mg Three times weekly · onset 1-2 weeks
Open the Thymopoietin calculatorThymopoietin calculator